Over-expression of Eph and ephrin genes in advanced ovarian cancer: Ephrin gene expression correlates with shortened survival

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Herath, Nirmitha I ^a   Spanevello, Mark D ^a   Sabesan, Sabe ^a   Newton, Tanya ^a   Cummings, Margaret ^a   Duffy, Shannon ^a   Lincoln, Douglas ^a   Boyle, Glen ^a   Parsons, Peter G ^a   Boyd, Andrew W ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN; EPHRIN A1; EPHRIN A2; EPHRIN A3; EPHRIN A4; EPHRIN A5; EPHRIN B1; EPHRIN B2; EPHRIN RECEPTOR; EPHRIN RECEPTOR A1; EPHRIN RECEPTOR A2; EPHRIN RECEPTOR A3; EPHRIN RECEPTOR A4; EPHRIN RECEPTOR A5; EPHRIN RECEPTOR A6; EPHRIN RECEPTOR A7; EPHRIN RECEPTOR A8; EPHRIN RECEPTOR B1; EPHRIN RECEPTOR B2; EPHRIN RECEPTOR B3; EPHRIN RECEPTOR B4; EPHRIN RECEPTOR B6;

ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CELL ADHESION; CELL MOTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; GYNECOLOGIC CANCER; HUMAN; KAPLAN MEIER METHOD; NUCLEOTIDE SEQUENCE; OVARY CANCER; PHENOTYPIC VARIATION; PROGNOSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; SURVIVAL TIME;

DISEASE PROGRESSION; EPHRIN-A1; EPHRIN-A2; EPHRIN-A5; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; PHENOTYPE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 33745938939     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-144     Document Type: Article

References (28)

1. Boyd AW, Lackmann M: Signals from Eph and ephrin proteins: a developmental tool kit. Sci STKE 2001, RE20:.
2. Gale NW, Holland SJ, Valenzuela DM, Flenniken A, Pan L, Ryan TE, Henkemeyer M, Strebhardt K, Hirai H, Wilkinson DJ, Pawson T, Davis S, Yancoupoulos GD: Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalised during embryogenesis. Neuron 1996, 17:9-19.
3. Coulthard MG, Duffy S, Down M, Evans B, Power M, Smith F, Stylianou C, Kleikamp S, Oates A, Lackmann M, Burns GF, Boyd AW: The role of the Eph-ephrin signalling system in the regulation of developmental patterning. Int J Dev Biol 2002, 46:375-384.
4. Klein R: Bidirectional signals establish boundaries. Curr Biol 1991, 9:R691-R694.
5. Nakamoto M, Bergemann AD: Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis. Microsc Res Tech 2002, 59:58-67.
6. Batlle E, Henderson JT, Beghtel H, van den Bron MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T, Clevers H: Beta-Catenin and TCF mediate cell Positioning in the intestinal epithelium by controlling the expression of EphB/ephrin B. Cell 2002, 111:251-263.
7. Sancho E, Batlle E, Clevers H: Live and let die in the intestinal epithelium. Curr Opin Cell Biol 2003, 15:763-770.
8. Kataoka H, Tanaka M, Kanamori M, Yoshii S, Ihara M, Wang YJ, Song JP, Li ZY, Arai H, Otsuki Y, Kobayashi T, Konno H, Hanai H, Sugimura H: Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer. J Cancer Res Clin Oncol 2002, 28:343-348.
9. Stephenson SA, Slomka S, Douglas EL, Hewett PJ, Hardingham JE: Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer. BMC Mol Biol 2001, 2:15.
10. Berclaz G, Flutsch B, Altermatt HJ, Rohrback H, Djonov V, Ziemiecki A, Dreher E, Andres AC: Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast. Oncol Rep 2002, 9:985-989.
11. Nikolova Z, Djonov V, Zuercher G, Andres AC, Ziemiecki A: Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin B2 during mammary gland morphogenesis. J Cell Sci 1998, 111:2741-51.
12. Liu W, Ahmad SA, Jung YD, Reinmuth N, Fan F, Bucana CD, Ellis LM: Co-expression of ephrin-Bs and their receptors in colon carcinoma. Cancer 2002, 94:934-939.
13. Hirai H, Maru Y, Hagiwara K, Nishida J, Takaku F: A novel putative tyrosine kinase receptor encoded by the eph gene. Science 1987, 238:1717-20.
14. Coulthard MG, Lickliter JD, Subanesan N, Chen K, Webb GC, Lowry AJ, Koblar S, Bottema CD, Boyd AW: Characterisation of the EphA1 receptor tyrosine kinase: expression in epithelial tissues. Growth Factors 2001, 18:303-317.
15. Robinson D, He F, Pretlow T, Kung HJ: A tyrosine kinase profile of prostate carcinoma. Proc Natl Acad Sci USA 1996, 93:5958-62.
16. Kao HW, Chen HC, Wu CW, Lin WC: Tyrosine-kinase expression profiles in human gastric cancer cell lines and their modulations with retinoic acids. Br J Cancer 2003, 88:1058-1064.
17. Maru Y, Hirai H, Yoshida MC, Takaku F: Evolution, expression and chromosomal location of a novel receptor tyrosine kinase gene, eph. Molecular & Cellular Biology 1998, 8:3770-6.
18. Miyazaki T, Kato H, Fukuchi M, Nakajima M, Kuwano H: EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int J Cancer 2003, 103:657-663.
19. Zelinski DP, Zantek ND, Stewart JC, Irizarry AR, Kinch MS: EphA2 over-expression causes tumorigenesis of mammary epithelial cells. Cancer Res 2001, 61:2301-2306.
20. Kinch MS, Moore MB, Harpole DH: Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. Clin Cancer Res 2003, 9:613-618.
21. Rosenberg IM, Goke M, Kanai M, Reinecker HC, Podolsky DK: Eplthelial cell kinase-B61:an autocrine loop modulating intestinal epithelial migration and barrier function. Am J Physiol 1997, 273:G824-G832.
22. Dodelet VC, Pasquale EB: Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene 2000, 19:5614-5619.
23. Kullander K, Klein R: Mechanisms and function of eph and ephrin signalling. Nat Rev Mol Cell Biol 2002, 3:475-486.
24. Han L, Dong Z, Qiao Y, Kristensen GB, Holm R, Nesland JM, Suo Z: The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinoma. Gynecol Oncol 2005, 99:278-86.
25. Maru Y, Hirai H, Takaku F: Over-expression confers an oncogenic potential upon the eph gene. Oncogene 1990, 5:445-7.
26. Easty DJ, Guthrie BA, Maung K, Farr CJ, Lindberg RA, Toso RJ, Herlyn M, Bennett DC: Protein B6 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. Cancer Research 1995, 55:2528-32.
27. Straume O, Akslen LA: Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin A1/EphA2 on melanoma progression. Am J Pathol 2002, 160:1009-1019.
28. Kozlosky CJ, VandenBos T, Park L, Cerretti DP, Carpenter MK: LERK-7: a ligand of the Eph-related kinases is developmentally regulated in the brain. Cytokine 1997, 9:540-9.